Scarica l'app Stockscreener
21.75
2.26%
0.48
Precedente Chiudi:
$21.27
Aprire:
$21.16
Volume 24 ore:
348.71K
Relative Volume:
0.63
Capitalizzazione di mercato:
$1.29B
Reddito:
-
Utile/perdita netta:
$-85.21M
Rapporto P/E:
-11.51
EPS:
-1.89
Flusso di cassa netto:
$-68.53M
1 W Prestazione:
-1.45%
1M Prestazione:
+2.64%
6M Prestazione:
+28.47%
1 anno Prestazione:
-14.40%
Intervallo 1D:
$20.37
$22.05
Intervallo di 1 settimana:
$20.37
$23.31
Portata 52W:
$13.30
$26.09
Enliven Therapeutics Inc Stock (ELVN) Company Profile
Nome
Enliven Therapeutics Inc
Settore
Industria
Telefono
720-647-8519
Indirizzo
6200 LOOKOUT ROAD, BOULDER
Confronta ELVN con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
ELVN
Enliven Therapeutics Inc
|
21.75 | 1.26B | 0 | -85.21M | -68.53M | -1.89 |
|
VRTX
Vertex Pharmaceuticals Inc
|
426.76 | 107.15B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
755.90 | 77.46B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
436.38 | 58.90B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
918.92 | 56.55B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
198.76 | 42.58B | 447.02M | -1.18B | -906.14M | -6.1812 |
Enliven Therapeutics Inc Stock (ELVN) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-06-16 | Iniziato | Goldman | Buy |
| 2024-12-13 | Iniziato | BTIG Research | Buy |
| 2024-09-09 | Iniziato | H.C. Wainwright | Buy |
| 2024-06-11 | Iniziato | Robert W. Baird | Outperform |
| 2024-04-09 | Iniziato | Mizuho | Buy |
| 2023-03-29 | Iniziato | Jefferies | Buy |
Mostra tutto
Enliven Therapeutics Inc Borsa (ELVN) Ultime notizie
Enliven Therapeutics Insider Sold Shares Worth $279,155, According to a Recent SEC Filing - MarketScreener
Will Enliven Therapeutics Inc. stock outperform international peersWeekly Market Report & AI Enhanced Trade Execution Alerts - newser.com
How Enliven Therapeutics Inc. stock reacts to Fed rate cutsGlobal Markets & Daily Technical Forecast Reports - newser.com
Why Enliven Therapeutics Inc. stock is favored by pension fundsWall Street Watch & Low Drawdown Investment Ideas - newser.com
What hedge fund activity signals for Enliven Therapeutics Inc. stock2025 Market Outlook & Weekly Top Gainers Alerts - newser.com
Is Enliven Therapeutics Inc. stock positioned well for digital economyMarket Risk Analysis & Expert-Curated Trade Recommendations - newser.com
Is Enliven Therapeutics Inc. stock a contrarian buy2025 Investor Takeaways & AI Powered Market Entry Ideas - newser.com
Enliven Therapeutics CEO Kintz sells $272k in shares By Investing.com - Investing.com Canada
What analyst consensus says on Enliven Therapeutics Inc. stockJuly 2025 Analyst Calls & Free Fast Gain Swing Trade Alerts - newser.com
Enliven Therapeutics Inc (ELVN) can make a big difference with a little luck - Setenews
Enliven Therapeutics: Notable Early Signals, But Too Many Assumptions To Justify A Buy - Seeking Alpha
Enliven Therapeutics CEO and CFO participate in Jefferies conference - Traders Union
Does Enliven Therapeutics, Inc. (ELVN) Have the Potential to Rally 87.49% as Wall Street Analysts Expect? - Yahoo Finance
What is Lifesci Capital’s Forecast for ELVN FY2025 Earnings? - Defense World
Price-Driven Insight from (ELVN) for Rule-Based Strategy - news.stocktradersdaily.com
Published on: 2025-11-16 16:06:17 - newser.com
Enliven Therapeutics, Inc. (NASDAQ:ELVN) Receives $41.20 Average Price Target from Brokerages - Defense World
Applying sector rotation models to Enliven Therapeutics Inc.Portfolio Value Report & Fast Moving Stock Trade Plans - newser.com
Can Enliven Therapeutics Inc. stock deliver strong Q4 earnings2025 Price Momentum & Growth Oriented Trade Recommendations - newser.com
Enliven Therapeutics (NASDAQ:ELVN) Rating Increased to Hold at Wall Street Zen - Defense World
Is Enliven Therapeutics Inc. stock a safe haven assetJuly 2025 Macro Moves & Free Expert Verified Stock Movement Alerts - newser.com
Published on: 2025-11-13 21:13:49 - newser.com
Automated trading signals detected on Enliven Therapeutics Inc.Portfolio Performance Summary & Step-by-Step Swing Trade Plans - newser.com
Enliven Therapeutics Inc. stock daily chart insights2025 Momentum Check & Free Community Supported Trade Ideas - newser.com
Decoding Enliven Therapeutics Inc (ELVN): A Strategic SWOT Insig - GuruFocus
Enliven Therapeutics Reports Q3 2025 Financial Results - TipRanks
Enliven Therapeutics Reports Third Quarter Financial Results and Provides a Business Update - PR Newswire
Published on: 2025-11-12 18:07:48 - newser.com
Enliven Therapeutics Keeps Moving Forward As Losses Narrow And Cash Holds Strong - Finimize
Enliven Therapeutics Inc Azioni (ELVN) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
1.38%
1.42%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):